Medicare Enrolled

Dr. Craig Teller, M.D.

Dermatology · Bellaire, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
6565 WEST LOOP S, Bellaire, TX 77401
7136614383
In practice since 2006 (20 years)
NPI: 1851351357 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Teller from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Teller? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Teller

Dr. Craig Teller is a dermatology in Bellaire, TX, with 20 years in practice. Based on federal Medicare data, Dr. Teller performed 1,377 Medicare services across 746 unique beneficiaries.

Between the years covered by Open Payments, Dr. Teller received a total of $1,312,059 from 43 pharmaceutical and/or device companies across 2072 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Teller is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ 1,377 Medicare services$ $1,312,059 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,377
Medicare services
Bottom 31% in TX for dermatology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
746
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~69 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Destruction of precancerous skin growths, 2-14607$5$25
Office visit, established patient (20-29 min)204$62$180
Destruction of precancerous skin growth, 1167$38$185
Skin biopsy, tangential120$70$220
Office visit, established patient (30-39 min)95$91$250
New patient office visit (30-44 min)44$77$272
Biopsy of related skin growth, each additional growth39$38$80
Destruction of precancer skin growth, 15 or more growths33$122$370
Destruction of skin growths (warts/lesions), 1-1430$83$215
Office visit, established patient (10-19 min)25$38$105
New patient office visit (45-59 min)13$124$400
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,312,059
Total received (2018-2024)
Avg $187,437/year across 7 years
Top 1% in TX for dermatology
43
Companies
2,072
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,095,729 (83.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$209,046 (15.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,283 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$208,944
2023
$258,450
2022
$175,919
2021
$95,016
2020
$96,998
2019
$243,515
2018
$233,216

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AbbVie Inc.
$198,191
ABBVIE INC.
$137,138
Regeneron Healthcare Solutions, Inc.
$115,903
Allergan, Inc.
$109,223
AbbVie, Inc.
$103,114
Allergan Inc.
$89,100
Janssen Scientific Affairs, LLC
$85,262
Arcutis Biotherapeutics, Inc.
$76,412
GENZYME CORPORATION
$76,194
Janssen Biotech, Inc.
$47,823
UCB, Inc.
$45,705
Lilly USA, LLC
$44,982
Amgen Inc.
$39,849
E.R. Squibb & Sons, L.L.C.
$36,692
Celgene Corporation
$28,486
Novartis Pharmaceuticals Corporation
$23,761
Genentech USA, Inc.
$12,504
Galderma Laboratories, L.P.
$8,710
Ortho Dermatologics, a division of Bausch Health US, LLC
$6,524
NOVARTIS PHARMACEUTICALS CORPORATION
$5,461
LEO Pharma Inc.
$5,364
Taro Pharmaceuticals USA, Inc.
$4,450
Almirall LLC
$2,993
TARO PHARMACEUTICALS USA, INC.
$2,616
Encore Dermatology Inc.
$1,695
Merz North America, Inc.
$888
MERZ NORTH AMERICA, INC.
$688
PFIZER INC.
$561
Regeneron Pharmaceuticals, Inc.
$485
Dermavant Sciences, Inc.
$434
Sun Pharmaceutical Industries Inc.
$185
Incyte Corporation
$156
SANOFI-AVENTIS U.S. LLC
$154
Boehringer Ingelheim Pharmaceuticals, Inc.
$147
Biofrontera Inc.
$53
VYNE Pharmaceuticals Inc.
$34
Verrica Pharmaceuticals Inc.
$31
Mayne Pharma Inc.
$26
Sandoz Inc.
$19
Helsinn Therapeutics (U.S.), Inc.
$17
Tactile Systems Technology Inc
$14
Bard Peripheral Vascular, Inc.
$7
Venclose Inc.
$6
Top 3 companies account for 34.4% of total payments
Associated products mentioned in payments ›
0.25% · ABSORICA LD · ADBRY · AMELUZ · AMZEEQ · BOTOX · BOTOX COSMETIC · Bimzelx · CIBINQO · COSENTYX · Cimzia · DISEASE STATE · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EPIDUO · EPIDUO FORTE · EPSOLAY · EUCRISA · EVRSF · Enbrel · FLEXITOUCH · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Impoyz · KYBELLA · Klisyri · LIBTAYO · OLUMIANT · OPZELURA · ORACEA · Otezla · PICATO · REMICADE · RINVOQ · SEYSARA · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Skyrizi · Sotyktu · TALTZ · TOPICORT · TOPICORT (desoximetasone) Topical Spray · TREMFYA · TRI-LUMA · TRILUMA · TWYNEO · Tremfya · ULTRAVATE (halobetasol propionate) lotion · VALCHLOR · VTAMA · Veltin · Venclose · Winlevi · XEOMIN · Xolair · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (84%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in dermatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for dermatology in TX.

Equivalent to $95,284 per 100 Medicare services performed
Looking for a dermatology in Bellaire?
Compare dermatologys in the Bellaire area by procedure volume, costs, and industry payment transparency.
Browse dermatologys nearby

Geographic Context

Dermatologys within 10 mi
253
Per 100K population
5.3
County median income
$73,104
Nearest hospital
BEHAVIORAL HOSPITAL OF BELLAIRE
1.2 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Teller is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 1%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Teller experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Teller performed 607 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Teller receive payments from pharmaceutical companies?
Yes. Dr. Teller received a total of $1,312,059 from 43 companies across 2,072 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Teller's costs compare to other dermatologys in Bellaire?
Dr. Teller's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Teller) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →